🔗 Share this article

Chancellor Reeves has stated she is preparing "specific action to tackle cost of living pressures" in next month's Budget.

During an interview with media outlets, she stated that reducing price rises is a shared task of both the administration and the central bank.

The United Kingdom's inflation rate is expected to be the most elevated among the G7 developed nations this year and the following year.

Potential Utility Bill Measures

It is understood the government could intervene to lower utility costs, for example by reducing the current 5% level of VAT applied on energy.

Another approach is to reduce some of the regulatory levies currently added to household expenses.

Fiscal Constraints and Expert Expectations

The government will obtain the next assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much scope there is for these actions.

The consensus from most economists is that the Chancellor will have to introduce tax increases or expenditure reductions in order to fulfill her declared borrowing rules.

Earlier on the same day, calculations suggested there was a £22 billion deficit for the Treasury chief to resolve, which is at the more modest range of forecasts.

"It is a joint responsibility between the central bank and the government to bear down further on some of the drivers of price increases," the Chancellor informed the BBC in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Commitments and Global Issues

While a great deal of the attention has been on expected tax rises, the Treasury chief said the latest figures from the fiscal watchdog had not altered her pledge to election pledges not to raise rates on income tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with increasing geopolitical and trade concerns for the fiscal revenue measures, probably to be targeted on those "with the broadest shoulders."

Global Trade Tensions

Referring to apprehensions about the United Kingdom's trade ties with the Asian nation she said: "The UK's security interests always are paramount."

Recent declaration by China to tighten export controls on critical minerals and other resources that are key for high-technology manufacturing led American leader Donald Trump to threaten an extra 100% tariff on imports from the Asian country, increasing the risk of an full-scale commercial conflict between the two global powers.

The US Treasury Secretary called the Chinese action "commercial pressure" and "a international production power grab."

Inquired about considering the American proposal to participate in its dispute with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and called on the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "damaging for the global economy and causes further headwinds."

"I believe there are fields where we must challenge China, but there are also important chances to trade with Chinese markets, including financial services and other areas of the economic system. We've got to maintain that equilibrium appropriate."

The chancellor also confirmed she was working with G7 counterparts "regarding our own essential resources plan, so that we are reduced dependence."

NHS Medicine Pricing and Investment

The Chancellor also recognized that the price the National Health Service spends on medicines could increase as a result of ongoing talks with the Trump administration and its pharmaceutical firms, in return for lower tariffs and funding.

Some of the world's largest drug companies have said lately that they are either delaying or canceling projects in the United Kingdom, with several attributing the modest returns they are getting.

Recently, the government science advisor said the cost the health service pays for medicines would need to go up to prevent companies and drug research funding departing from the UK.

The Chancellor informed the BBC: "We have seen due to the cost structure, that medical research, recent pharmaceuticals have not been available in the UK in the way that they are in other European countries."

"We want to ensure that people receiving treatment from the National Health Service are can access the best critical medicines in the globe. And so we are reviewing all of that, and... seeking to attract increased investment into the UK."